Showing results (71-80 of 381) with videos related to
Sort By:
Pageof 39
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Clinical evaluation of a new cosmetic cream containing PEPHA®-TIGHT on the skin of childbearing womenP Amori, J Lotti, T Lotti, et al.Journal of Wound Care|December 14, 2016
Wound-healing problems associated with cancersT Lotti, C Rodofili, M Bend, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2002
Development of oesophageal involvement in a subject with pemphigus vulgaris: a case report and review of the literatureG M Palleschi, E M Cipollini, T LottiThe Journal of International Medical Research|July 1, 1987
Ciprofloxacin in the treatment of urinary tract infectionsT Lotti, V Mirone, C Imbimbo, et al.Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 9, 2010
A severe complication of anti-TNF alfa treatmentC Fabroni, A Gori, F Prignano, et al.European Urology|March 19, 1999
Role of neoadjuvant treatment in clinically confined prostate cancer. Takeda NHT Italian GroupD Prezioso, T Lotti, R Montironi, et al.Minerva Medica|April 1, 1996
[Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial]V Mirone, D Prezioso, A Palmieri, et al.European Urology|January 1, 1984
Mucinous adenocarcinoma of the renal pelvisV Mirone, D Prezioso, S Palombini, et al.Biologics : Targets & Therapy|August 27, 2009
Efalizumab-induced severe thrombocytopenia can be resolvedFrancesca Prignano, F Zanieri, S Mokhtarzadeh, et al.Dermatologic Therapy|July 8, 2009
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case reportF Prignano, F Zanieri, S Milani, et al.Pageof 39